Supreme Court Affirms ACA’s Preventive Care Requirement

On June 27, 2025, in Kennedy v. Braidwood Management, Inc., the U.S. Supreme Court issued a pivotal 6–3 ruling upholding a key provision of the Affordable Care Act (ACA). The Court maintained that private health plans must continue covering a range of preventive services, including cancer screenings, heart-health medications, immunizations, and HIV prevention drugs like PrEP, without any cost-sharing for patients.

The core constitutional challenge centered on the U.S. Preventive Services Task Force (USPSTF), a panel empowered by the ACA to determine which preventive services deserve “A” or “B” ratings and, therefore, mandatory coverage. Plaintiffs argued that task force members were “principal officers” who must be appointed by the President and confirmed by the Senate under the Constitution’s Appointments Clause. They contended that the panel’s recommendations were legally binding, not advisory, making compliance with Senate confirmation necessary.

Legal Reasoning: Appointments Clause Meets Administrative Oversight

Justice Brett Kavanaugh, writing for the majority, rejected the plaintiffs’ framing by recognizing the USPSTF panel members as “inferior officers,” a constitutional category that avoids Senate confirmation. According to Kavanaugh, two factors ensured compliance with the Appointments Clause:

1. At-will removal by the HHS Secretary, making the panel subject to executive oversight.
2. Express statutory authority for review, permitting the.

Thus, because the Health and Human Services (HHS) Secretary, accountable to the President, can oversee and veto USPSTF actions, the panel satisfies constitutional demands.

Dissenters Voice Fears Over Erosion of Appointment Restrictions

Justices Clarence Thomas, Samuel Alito, and Neil Gorsuch dissented, asserting that the task force wields too much power without proper Senate oversight. Justice Thomas argued that Congress intended independent authority for the USPSTF, highlighting that its structure effectively sidesteps the Constitution’s requirement for Senate-confirmed appointments.

Practical Impact: Securing Preventive Care for Millions

The Supreme Court’s ruling safeguards preventive care coverage for roughly 150 million privately insured Americans. This coverage spans a broad array of services, including:

• Cancer screenings: mammograms, colonoscopies, lung cancer checks.
• Cholesterol-lowering drugs like statins to prevent heart disease.
• Immunizations recommended by the CDC’s advisory panels.
• HIV prevention, including pre-exposure prophylaxis (PrEP).

Public health advocates, such as the HIV+Hepatitis Policy Institute, hailed the decision, noting that cost-free access to PrEP and other preventive services helps limit the spread of infectious diseases and supports early interventions for chronic conditions.

Political Oversight: A Double-Edged Sword

While the decision affirms coverage continuity, it also reinforces the HHS Secretary’s authority to steer USPSTF recommendations. Under HHS Secretary Robert F. Kennedy Jr., there have already been notable shifts, such as dismissing the CDC vaccine advisory committee members and replacing them with ideologically aligned individuals. This underscores a tension between accountability and the risk of politicization. Politically answerable health leadership may increase transparency, yet ideological influence could disrupt evidence-based public health guidance. As Dorit Reiss from UC San Francisco remarked to The Guardian, this ruling “strengthens the control of political appointees over the bureaucracy,” raising concerns about future interference in science-based recommendations.

Reacting to the Decision: For Consumers, Providers, Policymakers

Consumers

Insured individuals can rest assured that they will continue receiving essential preventive services without co-pays or deductibles. However, they should remain informed about any changes to covered services through official USPSTF updates or provider communications.

Healthcare Providers

Clinicians can rely on the stability of preventive service requirements, but they should be alert to new recommendations. Coordination with insurers and staying aware of shifting policy direction at HHS will be key.

Policymakers

State and federal lawmakers should consider legislative safeguards ensuring scientific integrity and minimizing partisan manipulation of preventive health guidelines. Some states may explore augmenting protections at the state policy level.

Conclusion: A Victory with Vigilance

The Supreme Court’s Kennedy v. Braidwood decision reinforces an ACA provision vital to public health, ensuring that no-cost preventive care remains accessible to millions. At the same time, it formalizes the significant influence of the HHS Secretary over the USPSTF, underscoring the importance of monitoring future administrative actions. For consumers and providers, the ruling is welcome news, but it also carries a reminder: health policy remains shaped not only by law, but also by politics.